Ulf Schutter

Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial

O. Löwenstein, Petra Leyendecker, Michael Hopp et al. · Expert Opinion on Pharmacotherapy · 2009 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +17

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

Desmond Curran, Ruprecht Schmidt‐Ott, Ulf Schutter et al. · BMC Infectious Diseases · 2018 · 82 citations · Full text

Medicine, Dermatology, Neurology +17

Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice

Ulf Schutter, S. Grunert, Christian Meyer et al. · Current Medical Research and Opinion · 2010 · 62 citations

Medicine, Pharmacology, Pharmacotherapy +17

Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study

Ruprecht Schmidt‐Ott, Ulf Schutter, Jörg Simon et al. · Journal of Infection · 2018 · 42 citations · Full text

Medicine, Dermatology, Neurology +10

[The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].

Ulf Schutter, Ingrid Ritzdorf, Birgit Heckes · PubMed · 2010 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +11